[1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum

C79H67N5OPt-2 — CID 168796666

IUPAC[1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum
SMILESCC(C)(C)c1cc(-n2c(=[Pt])n(-c3[c-]c(Oc4[c-]c5c(cc4)C4(c6ccccc6N5c5cc(C(C)(C)C)ccn5)c5cc(-c6ccccc6)ccc5N(c5ccccc5)c5ccc(-c6ccccc6)cc54)ccc3)c3ccccc32)cc(C(C)(C)C)c1
InChIInChI=1S/C79H67N5O.Pt/c1-76(2,3)57-42-43-80-75(49-57)84-69-33-20-19-32-65(69)79(67-44-55(53-24-13-10-14-25-53)36-40-70(67)83(60-28-17-12-18-29-60)71-41-37-56(45-68(71)79)54-26-15-11-16-27-54)66-39-38-64(51-74(66)84)85-63-31-23-30-61(50-63)81-52-82(73-35-22-21-34-72(73)81)62-47-58(77(4,5)6)46-59(48-62)78(7,8)9;/h10-49H,1-9H3;/q-2;
InChIKeyRKKQTRKBVOQNMU-UHFFFAOYSA-N
MW1297.52 g/mol
LogP20.46
Rot. Bonds8

About [1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum

[1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum (PubChem CID 168796666) has the molecular formula C79H67N5OPt-2 and a molecular weight of 1297.52 g/mol. Its IUPAC name is [1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum.

Molecular Properties

Compound Name[1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum
PubChem CID168796666
Molecular FormulaC79H67N5OPt-2
Molecular Weight1297.52 g/mol
Exact Mass1296.50
IUPAC Name[1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum
SMILESCC(C)(C)c1cc(-n2c(=[Pt])n(-c3[c-]c(Oc4[c-]c5c(cc4)C4(c6ccccc6N5c5cc(C(C)(C)C)ccn5)c5cc(-c6ccccc6)ccc5N(c5ccccc5)c5ccc(-c6ccccc6)cc54)ccc3)c3ccccc32)cc(C(C)(C)C)c1
InChIInChI=1S/C79H67N5O.Pt/c1-76(2,3)57-42-43-80-75(49-57)84-69-33-20-19-32-65(69)79(67-44-55(53-24-13-10-14-25-53)36-40-70(67)83(60-28-17-12-18-29-60)71-41-37-56(45-68(71)79)54-26-15-11-16-27-54)66-39-38-64(51-74(66)84)85-63-31-23-30-61(50-63)81-52-82(73-35-22-21-34-72(73)81)62-47-58(77(4,5)6)46-59(48-62)78(7,8)9;/h10-49H,1-9H3;/q-2;
InChIKeyRKKQTRKBVOQNMU-UHFFFAOYSA-N
XLogP20.46
TPSA38.46 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms86
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001297.52
LogP ≤ 520.46
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze [1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum?
The IUPAC name of [1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum (CID 168796666) is [1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum.
What is the SMILES notation for [1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum?
The canonical SMILES for [1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum is CC(C)(C)c1cc(-n2c(=[Pt])n(-c3[c-]c(Oc4[c-]c5c(cc4)C4(c6ccccc6N5c5cc(C(C)(C)C)ccn5)c5cc(-c6ccccc6)ccc5N(c5ccccc5)c5ccc(-c6ccccc6)cc54)ccc3)c3ccccc32)cc(C(C)(C)C)c1.
What is the InChIKey of [1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum?
The InChIKey is RKKQTRKBVOQNMU-UHFFFAOYSA-N. The full InChI is InChI=1S/C79H67N5O.Pt/c1-76(2,3)57-42-43-80-75(49-57)84-69-33-20-19-32-65(69)79(67-44-55(53-24-13-10-14-25-53)36-40-70(67)83(60-28-17-12-18-29-60)71-41-37-56(45-68(71)79)54-26-15-11-16-27-54)66-39-38-64(51-74(66)84)85-63-31-23-30-61(50-63)81-52-82(73-35-22-21-34-72(73)81)62-47-58(77(4,5)6)46-59(48-62)78(7,8)9;/h10-49H,1-9H3;/q-2;.
What are the key properties of [1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum?
[1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum has a molecular weight of 1297.52 g/mol, XLogP of 20.46, 8 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[3-[10-(4-tert-butyl-2-pyridinyl)-2',7',10'-triphenylspiro[4H-acridin-4-ide-9,9'-acridine]-3-yl]oxybenzene-2-id-1-yl]-3-(3,5-ditert-butylphenyl)benzimidazol-2-ylidene]platinum is sourced from PubChem (CID 168796666), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).